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Figure 1.1

Comparison of calcium dependent and calcium independent cell
adhesion molecule domains.
Members of the immunoglobulin superfamily are calcium independent and
contain disulfide bridges known to form the characteristic
immunoglobulin loop-like domains (top row). Other cell adhesion
molecule families are calcium dependent and do not contain disulfide
bridges (bottom row; Sonderegger, 1998).
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Figure 1.2

Coding regions of the Basigin gene.
The Basigin gene contains eight exons. Exons 1 through 7 encode the
Basigin protein consisting of two extracellular immunoglobulin domains.
Exons 1 through 7 in addition to exon 1A encode the Basigin-2 protein
consisting of the two identical immunoglobulin domains found in Basigin
in addition to a third immunoglobulin domain that is specific to the
Basigin-2 protein (adapted from Ochrietor et al., 2003).
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Figure 1.3

Western blot showing the expression of Basigin gene products in
mouse tissue.
An antibody that recognized both isoforms of Basigin indicates that the
Basigin protein is ubiquitously expressed (top panel). Basigin is
approximately 45 kDa in molecular weight while Basigin-2 is
approximately 55 kDa in molecular weight. An antibody specific to the
Basigin-2 isoform shows that Basigin-2 is a retina-specific isoform (bottom
panel). R = retina, B = brain, Lu = lung, Li = liver, K = kidney, H = heart, S =
spleen, U = uterus, T = testis, SM = skeletal muscle (Ochrietor et al., 2003).
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Figure 1.4

Toll-like receptor family members and their ligands.
All toll-like receptors contain leucine rich repeats that comprise the
extracellular domain and a TIR signaling domain comprising the
cytoplasmic tail (Armant and Fenton, 2002).
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Figure 1.5

TLR4 signaling.
Intracellular signaling through the MyD88 pathway in response to
activation of TLR4 by LPS (Parham, 2015).
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Figure 1.6

TLR4 is expressed in rodent cardiomyocytes and is upregulated in
response to hypertension.
Immunohistochemistry showing expression of TLR4 in rat
cardiomyocytes. A. TLR4 was detected in control rats that were
normotensive (WKY). B. Rats that experienced hypertension (SHR)
showed an upregulation of TLR4 in cardiomyocytes compared to
normotensive rats. C. Ramipril was given as a treatment to reduce
hypertension in SHR rats simultaneously reversing TLR4 upregulation
(Eissler et al., 2011).

Table 2.1

Basigin transmembrane domain mutagenesis primers.

18

Figure 3.1

TLR4 is present in mouse heart and was not detected in retina or
brain.
Wells were coated with either retina lysates (A), brain lysate (B), or heart
lysate (C) and bovine serum albumin (BSA) at 100 g/mL. An antibody
specific for the TLR4 protein (Pierce/ Thermo Scientific) was applied
directly to the immobilized proteins and an alkaline phosphataseconjugated goat anti-rabbit (AP-GAR) antibody was subsequently applied
(Pierce/Thermo Scientific). Binding was measured using an alkaline
phosphatase detection system and spectrophotometric analysis at 405 nm.
Error bars represent standard deviations of the mean. A Student’s T test
was performed to compare detection of TLR4 in retina to the negative
control (BSA). * indicates a p-value of less than 0.05.
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Figure 3.2

Basigin is present in mouse heart.
Wells were coated with mouse heart proteins or bovine serum albumin
(BSA) at 100 g/mL. An antibody specific for the Basigin protein
(Ochrietor et al., 2003) was applied directly to the proteins and an alkaline
phosphatase-conjugated
goat
anti-mouse
(AP-GAM)
antibody
(Pierce/Thermo Scientific) was subsequently applied. Binding was
measured using an alkaline phosphatase detection system and subsequent
spectrophotometric analysis at 405 nm. Error bars represent standard
deviations of the mean. A Student’s T test was performed to compare
detection of Basigin in mouse heart to the negative control (BSA).
* indicates a p-value of less than 0.05.
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Figure 3.3

The Basigin transmembrane domain binds to TLR4.
The TLR4 protein was captured from mouse heart lysates using an
antibody specific for TLR4 (Pierce/Thermo Scientific). The appropriate
recombinant Basigin proteins were applied (BasTM or BasTM E13G) and a
primary antibody specific for the six histidine tag (BD Biosciences) present
on the recombinant proteins was applied. An alkaline phosphataseconjugated goat anti-mouse (AP-GAM) antibody (Pierce/Thermo
Scientific) was added and binding was measured using an alkaline
phosphatase detection system and spectrophotometric analysis at 405 nm.
Error bars represent standard deviations of the mean. A Student’s T test
was performed to compare detection of Basigin in mouse heart to the
negative control (control). * indicates a p-value of less than 0.05.
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Figure 3.4

A binding affinity assay for Basigin transmembrane domain binding
to TLR4.
Endogenous TLR4 was captured and incubated with recombinant Basigin
transmembrane domain (BasTM) at 0.5, 1.0, 1.5, 2.5, and 5.0 M. Binding
between endogenous TLR4 and the recombinant Basigin protein was
measured using an alkaline phosphatase detection system and
spectrophotometric assay at 405 nm. Percent binding was calculated for
each concentration and the binding affinity of the recombinant Basigin
protein for TLR4 was determined from the slope equation. All runs were
performed in triplicate. Error bars represent standard deviations of the
mean.
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Figure 3.5

A binding affinity assay for BasTM E13G binding to TLR4.
Endogenous TLR4 was captured and incubated with recombinant Basigin
transmembrane domain in which the glutamate residue was mutated
(BasTM E13G) at 0.5, 1.0, 1.5, 2.5, and 5.0 M. Binding between
endogenous TLR4 and the recombinant Basigin protein was measured
using an alkaline phosphatase detection system and spectrophotometric
assay at 405 nm. Percent binding was calculated for each concentration
and the binding affinity of the mutated recombinant Basigin protein for
TLR4 was determined using the slope equation. All runs were performed
in triplicate. A Student’s T-Test was used to compare the mutated
transmembrane binding affinity to that of the normal Basigin
transmembrane domain. A p-value of less than 0.05 is considered
statistically significant. Error bars represent standard deviations of the
mean.
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vi

Figure 3.6

Basigin transmembrane segments 7-12, 13-18, and 19-24 bind to
TLR4.
Endogenous TLR4 was captured using an antibody specific to TLR4
(Pierce/Thermo Scientific) and was incubated with the appropriate
recombinant Basigin protein (BasTM 1-6 6XHis, BasTM 7-12 6Xhis, BasTM
13-18 6Xhis, and BasTM 19-24 6Xhis) followed by the application of a
primary antibody specific for the six histidine tag (BD Biosciences). An
alkaline phosphatase-conjugated goat anti-mouse (AP-GAM) antibody
(Pierce/Thermo Scientific) was applied. Binding was measured using an
alkaline phosphatase detection system and spectrophotometric analysis at
405 nm. Error bars represent standard deviations of the mean. A
Student’s T test was performed to compare binding of Basigin
transmembrane segments to TLR4 in mouse heart to the control protein.
* indicates a p-value of less than 0.05.
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Figure 3.7

Binding affinity assays for BasTM segment binding to TLR4.
Endogenous TLR4 was captured and incubated with recombinant Basigin
transmembrane domain segments (BasTM 1-6, BasTM 7-18, BasTM 7-12,
BasTM 13-18, BasTM 19-24) at 0.5, 1.0, 1.5, 2.5, and 5.0 M. Binding
between endogenous TLR4 and the recombinant Basigin protein was
measured using an alkaline phosphatase detection system and
spectrophotometric assay at 405 nm. Percent binding was calculated for
each concentration and the binding affinity of the recombinant Basigin
protein for TLR4 was determined from the slope equation. All runs were
performed in triplicate. Error bars represent standard deviations of the
mean.
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Table 3.1

Comparison of Basigin transmembrane segment binding affinities for
TLR4.
Statistical analyses were performed to compare the binding affinities of
BasTM and BasTM segments for TLR4 using three distinct mouse hearts.
Average values were calculated for each protein construct and the percent
binding was determined. The concentration at which the percent binding
of the recombinant Basigin protein was 50% was calculated. The
calculated binding affinities of each recombinant protein were compared
using a Student’s T-test to obtain a p-value. The standard deviation was
calculated for binding affinities from each mouse heart.
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Figure 3.8

ELISA analysis comparing BasTM 1-6 to recombinant proteins
containing consecutive amino acid substitutions to glycine (G) within
the BasTM 1-6 segment.
All of these recombinant proteins were compared by the amount of
binding to TLR4. An antibody specific for the TLR4 protein was plated
followed by an application of mouse heart lysate. The appropriate
recombinant Basigin proteins were applied (BasTM 1-6 M1G 6XHis,
BasTM 1-6 A2G 6XHis, BasTM 1-6 A3G 6XHis, BasTM 1-6 L4G 6XHis,
BasTM 1-6 W5G 6XHis, and BasTM 1-6 P6G 6XHis) and a primary antibody
specific for the six histidine tag was applied. An alkaline phosphataseconjugated goat anti-mouse (AP-GAM) antibody was subsequently applied.
Binding was measured using an alkaline phosphatase detection system
and subsequent spectrophotometric analysis at 405 nm. Error bars
represent standard deviations of the mean. A Student’s T test was
performed to compare binding of Basigin transmembrane segments to
TLR4 in mouse heart to the control protein. * indicates a p-value of less
than 0.05.
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Figure 3.9

ELISA analysis comparing BasTM 7-12 to recombinant proteins
containing consecutive amino acid substitutions to glycine (G) within
the BasTM 7-12 segment.
All of these recombinant proteins were compared by the amount of binding
to TLR4. An antibody specific for the TLR4 protein was plated followed by
an application of mouse heart lysate. The appropriate recombinant Basigin
proteins were applied (BasTM 7-12 F7G 6XHis, BasTM 7-12 L8G 6XHis,
BasTM 7-12 I10G 6XHis, BasTM 7-12 V11G 6XHis, BasTM 7-12 A12G 6XHis,
and BasTM 7-12 6XHis) and a primary antibody specific for the six
histidine tag was applied. An alkaline phosphatase-conjugated goat antimouse (AP-GAM) antibody was subsequently applied. Binding was
measured using an alkaline phosphatase detection system and subsequent
spectrophotometric analysis at 405 nm. Error bars represent standard
deviations of the mean. A Student’s T test was performed to compare
binding of Basigin transmembrane segments to TLR4 in mouse heart to the
control protein. * indicates a p-value of less than 0.05.
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viii

Figure 3.10

ELISA analysis comparing BasTM 13-18 to recombinant proteins
containing consecutive amino acid substitutions to glycine (G) within
the BasTM 13-18 segment.
All of these recombinant proteins were compared by the amount of
binding to TLR4. An antibody specific for the TLR4 protein was plated
followed by an application of mouse heart lysate. The appropriate
recombinant Basigin proteins were applied (BasTM 13-18 E13G 6XHis,
BasTM 13-18 V14G 6XHis, BasTM 13-18 L15G 6XHis, BasTM 13-18 V16G
6XHis, BasTM 13-18 L17G 6XHis, and BasTM 13-18 V18G 6XHis) and a
primary antibody specific for the six histidine tag was applied. An alkaline
phosphatase-conjugated goat anti-mouse (AP-GAM) antibody was
subsequently applied.
Binding was measured using an alkaline
phosphatase detection system and subsequent spectrophotometric
analysis at 405 nm. Error bars represent standard deviations of the mean.
A Student’s T test was performed to compare binding of Basigin
transmembrane segments to TLR4 in mouse heart to the control protein.
* indicates a p-value of less than 0.05.
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Abstract
Toll-like receptors (TLRs) are a major group of pattern recognition receptors
expressed on the surface of immune cells that recognize molecular patterns associated
with all classes of pathogenic microorganisms. TLR4 recognizes the lipopolysaccharide
component of Gram-negative bacterial cell walls and is the only TLR known to induce
signaling through both the MyD88 and TRIF pathways. Basigin, a ubiquitous cell adhesion
molecule, is a member of the immunoglobulin superfamily that has the ability to influence
cell signaling mediated by the MyD88 and TRIF pathways, the same signaling pathways
induced by the TLR4 receptor protein. Analysis of the Basigin protein sequence indicates
the presence of a hydrophilic glutamate residue within the hydrophobic transmembrane
domain, but no consensus binding sites for MyD88 or TRIF. The purpose of this study was
to determine if Basigin uses TLR4 for signal transduction. It is hypothesized that Basigin
interacts with TLR4 and that the glutamate residue plays a role in the interaction. Enzymelinked immunosorbent binding assays were performed using endogenous TLR4 and
recombinant Basigin proteins. These analyses demonstrated that binding of Basigin to
TLR4 was significantly greater than that of the control protein and that the glutamate
residue in the Basigin transmembrane domain does play a role in the interaction between
Basigin and TLR4 as well as many hydrophobic residues in the Basigin transmembrane
domain. The data suggest that Basigin interacts with TLR4 to influence signaling cascades
using MyD88 and TRIF.
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Chapter 1 - Introduction
Immune-mediated pathogen recognition and destruction occurs via collaboration of
the innate and adaptive immune responses. The immune system is collectively comprised
of these two processes to facilitate host protection from deleterious factors within the
environment. The innate immune response is a rapidly generated early line of defense that
occurs as a result of pathogen recognition and works using antimicrobial peptides and the
complement system to eliminate pathogens (reviewed by Hendry et al., 2013). The innate
response is often sufficient in eliminating the identified invading pathogen, but in
circumstances where the innate response is insufficient, the adaptive response ensues and
functions until the pathogen is successfully eliminated (reviewed by Hendry et al., 2013).
Unlike the immediate response of innate immunity, adaptive immunity is long lasting and
responsible for the production of antibodies (reviewed by Hendry et al., 2013). The innate
immune system is initiated by the recognition of pathogenic organisms such as bacteria,
viruses, fungi, or parasites and involves various proteins including immune cell surface
receptors. Immune cell surface receptors directly interact with the pathogen or products
of the pathogen for the purpose of self- vs. non-self-discrimination, and thus these
recognizable products are specific to pathogenic entities. After pathogen recognition,
immune cell receptors are known to induce signaling cascades that result in the production
of pro-inflammatory cytokines and subsequent inflammation.

Cytokines generate

inflammatory responses by acting as signaling proteins that can recruit additional cells to
the site of injury or by increasing the number of white blood cells known as macrophages
at the site of infection for the purpose of increased phagocytosis (reviewed by Hendry et
al., 2013). Inflammation is the process by which heat, redness, pain, swelling, and even
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loss of function can occur at the local site of infection. A superabundance of inflammation
can result in septic shock (reviewed by Wiersinga et al., 2014)
Many key molecules are involved in the intricate processes of both innate and
adaptive immunity. Cell adhesion molecules are thought to play essential roles in the
immune response in addition to facilitating cell attachment, specifically by influencing proinflammatory intracellular signaling events and subsequent production of cytokines
(reviewed by Agrawal and Yong, 2011). Cell adhesion molecules also play large roles in
allowing immune cells to travel to and enter tissues from the bloodstream (reviewed by
Agrawal and Yong, 2011).
Cell adhesion molecules (CAMs) are transmembrane proteins involved in
extracellular recognition and cell attachment and can be categorized according to whether
or not they utilize calcium (Sonderegger, 1998). Molecules that are members of the
integrins, selectins, or cadherins are all calcium dependent, whereas members of the
immunoglobulin superfamily are calcium independent molecules (Sonderegger, 1998;
Figure 1.1). Molecules of the immunoglobulin superfamily are known for their roles in
facilitating cell adhesion in addition to activating signaling pathways within the cell
(Pollerberg et al., 2013). The members of the immunoglobulin superfamily can be defined
by extracellular regions that contain immunoglobulin-like domains formed by anti-parallel
β strands connected by loops of various lengths (Sonderegger, 1998). Disulfide bridges
link β-strands to form the characteristic immunoglobulin-like domains and are therefore
the distinguishing factors for this class of calcium-independent cell adhesion molecules
(Sonderegger, 1998).

2

Figure 1.1 Comparison of calcium dependent and calcium independent cell adhesion
molecule domains. Members of the immunoglobulin superfamily are calcium independent
and contain disulfide bridges known to form the characteristic immunoglobulin loop-like
domains (top row). Other cell adhesion molecule families are calcium dependent and do
not contain disulfide bridges (bottom row; Sonderegger, 1998).
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Basigin gene products are highly glycosylated members of the immunoglobulin
superfamily and function as cell adhesion molecules. Basigin gene products contain
immunoglobulin-like domains within the extracellular region, a hydrophobic single-pass
transmembrane domain, and a short cytoplasmic tail. The Basigin gene contains eight
exons from which two isoforms are produced via alternative splicing (Ochrietor et al.,
2003; Figure 1.2). Exons 1 through 7 encode the protein known as Basigin, which contains
two immunoglobulin-like domains (Ig 1 and 2) that comprise the extracellular region.
Exons 1 through 7, in addition to exon 1A (located between exon 1 and 2), encode the
Basigin-2 isoform, which contains three immunoglobulin-like domains that comprise the
extracellular region of the protein. Basigin-2 is a retina-specific isoform, while Basigin is
ubiquitously expressed (Figure 1.3). Although Basigin is best known for its role in cell
adhesion, various studies have indicated that Basigin is also involved in cancer metastasis,
regulation of associated signaling cascades, and pro-inflammatory intracellular signaling
cascades via interactions with the cyclophilin protein (Wei et al., 2010; Sidhu et al., 2010).
Basigin is thought to play an essential role in proper retinal function (Ochrietor et
al., 2001; Philp et al., 2003). In the retina, the Basigin gene codes for two polypeptides via
splice variation known as Basigin and Basigin-2 (Ochrietor et al., 2003). Basigin contains
two immunoglobulin-like loop domains and is ubiquitously expressed, whereas Basigin-2
contains three immunoglobulin-like loop domains and is a retina-specific isoform of the
Basigin gene (Ochrietor et al., 2003). It has been demonstrated that Basigin interacts with
Basigin-2 in the retina for the purpose of cell attachment (Ochrietor et al., 2008). It is
proposed that this interaction exists to facilitate proper nutrition of photoreceptor cells so
that phototransduction, and thus, proper vision can occur (Philp et al., 2003). Both

4

Figure 1.2 Coding regions of the Basigin gene. The Basigin gene contains eight exons.
Exons 1 through 7 encode the Basigin protein consisting of two extracellular
immunoglobulin domains. Exons 1 through 7 in addition to exon 1A encode the Basigin-2
protein consisting of the two identical immunoglobulin domains found in Basigin in
addition to a third immunoglobulin domain that is specific to the Basigin-2 protein
(adapted from Ochrietor et al., 2003).
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Figure 1.3 Western blot showing the expression of Basigin gene products in mouse tissue.
An antibody that recognized both isoforms of Basigin indicates that the Basigin protein is
ubiquitously expressed (top panel). Basigin is approximately 45 kDa in molecular weight
while Basigin-2 is approximately 55 kDa in molecular weight. An antibody specific to the
Basigin-2 isoform shows that Basigin-2 is a retina-specific isoform (bottom panel). R =
retina, B = brain, Lu = lung, Li = liver, K = kidney, H = heart, S = spleen, U = uterus, T = testis,
SM = skeletal muscle (Ochrietor et al., 2003).
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Basigin and Basigin-2 interact with monocarboxylate transporter 1 (MCT-1) via
hydrophobic interactions of the membrane-spanning domains (Finch et al., 2009).
Members of the MCT family transport lactate and other monocarboxylates across the
plasma membrane (Halestrap and Price, 1999). The expression pattern of Basigin and
Basigin-2 in the retina differ in that Basigin is expressed by Müller glial cells and Basigin-2
is expressed specifically by photoreceptor cells (Ochrietor et al., 2003). It is thought that
Basigin interacts with Basigin-2 to tether these two cell types together so that lactate is
able to move from Müller glial cells and into the photoreceptor cells (Philp et al., 2003).
Lactate can be utilized by photoreceptor cells to fuel oxidative phosphorylation and
generate energy for the process of phototransduction (Gladden, 2004).
Behavioral studies based on visual cues showed sensory malfunctions associated
with Basigin-null animals, which are thought to exist due to the absence of Basiginmediated cell adhesion in the brain (Naruhashi et al., 1997). Basigin-null animals are also
less sensitive to changes in light when compared to wild type animals in that the null
animals did not show any electroretinogram (ERG) responses (Hori et al., 2000; Ochrietor
et al., 2002). Studies have shown that animals in which the gene for Basigin is deleted lack
proper maturation of the retina and exhibit retinal degeneration (Ochrietor et al., 2001).
In addition to cell attachment, members of the immunoglobulin superfamily are
known to influence cell signaling. In humans, Basigin has been implicated as an essential
regulatory component in signaling pathways associated with cancer development and
metastasis (Sidhu et al., 2010). Lung epithelial tumor cells in which Basigin was increased
showed increased amounts of signaling through the Wnt/beta-catenin signaling pathway,
while decreases in Basigin resulted in decreased intracellular signaling (Sidhu et al., 2010).
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Basigin mRNA and protein were shown to be the most frequently up-regulated products in
metastatic cancer cells isolated from bone marrow, a correlation indicative of tumor
progression (reviewed by Nabeshima et al., 2006).

These findings demonstrate that

Basigin may behave as a regulatory component in the intracellular signaling and cell
attachment involved in tumor metastasis.
There is strong evidence for the involvement of Basigin in immune response
signaling and subsequent inflammation. In humans, Basigin was shown to induce proinflammatory intracellular signaling cascades in response to cyclophillin, a protein that is
characterized as a cytosolic peptidylprolyl isomerase that functions to catalyze the
isomerization of peptide bonds from trans to cis at proline amino acid residues (Wei et al.,
2010). Elevated cyclophillin levels are associated with atherosclerotic plaques, in which
monocytes and other cells secrete cyclophillin in response to reactive oxygen species.
Cyclophillin acts as a chemoattractant to recruit other immune cells and causes induction
of signaling inside the cell (Wei et al., 2010). Reactive oxygen species in immune cells are
commonly associated with pathogen internalization and precedes the inflammatory
response (Wei et al., 2010). Cyclophilin was shown to induce the MAP kinase pathway
through the Basigin protein, resulting in the activation of the transcription factor NFkappaB and subsequent release of pro-inflammatory cytokines. (Wei et al., 2010). The
study by Wei et al. demonstrated that the effects of cyclophillin were terminated when
Basigin was down-regulated, thus indicating that Basigin is required for mediating the
effects of cyclophillin.
Pattern recognition receptors (PRRs) are proteins expressed on the plasma
membrane of macrophages and other immune cell types that are extensively involved in
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pro-inflammatory signaling cascades associated with the innate immune response
(reviewed by Kawasaki et al., 2014). Some PRRs can be internalized within the cell for the
purpose of recognizing intracellular pathogens (reviewed by Kawasaki et al., 2014). PRRs
function to recognize common patterns that are characteristic of groups of pathogens
known as pathogen associated molecular patterns (Owen et al., 2013). These receptors
elicit pro-inflammatory signaling cascades that ultimately work to generate and secrete
chemical signals known as cytokines.

Cytokines label pathogens appropriately for

immune-mediated destruction, recruit immune cells to the site of infection, increase
vascular permeability, and allow immune cells to communicate effectively, all of which
elicits inflammation as part of the innate immune response (Owen et al., 2013). Pattern
recognition receptors often function as the first line of defense against foreign invaders
and include four classes of receptors: Toll-like receptors (TLRs), C-type lectin receptors
(CLRs), Retinoic acid-inducible gene I-like receptors (RLRs), and Nod-like receptors (NLRs)
(Owens et al., 2013).
Toll-like receptors are perhaps the most well understood and extensively studied
PRRs. Collectively, the toll-like receptor family recognizes all of the major classes of
pathogens including those from bacteria, viruses, fungi, and parasites (reviewed by
Kawasaki et al., 2014; Figure 1.4). TLRs have single membrane-spanning domains and
extensive extracellular domains consisting of many leucine-rich repeats that make up the
ligand-binding region of the receptor. The cytoplasmic domains interact with adaptor
proteins via toll-interferon-1 receptor (TIR) domains to induce signaling (Lu et al., 2008).
When members of the TLR family bind to their specific ligands, the receptors dimerize
either with themselves or, in some cases, with other members of the TLR family (Lu et al.,
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Figure 1.4 Toll-like receptor family members and their ligands. All toll-like receptors
contain leucine rich repeats that comprise the extracellular domain and a TIR signaling
domain comprising the cytoplasmic tail (Armant and Fenton, 2002).
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2008). TLR4 specifically recognizes lipopolysaccharide, a component of Gram-negative
bacterial cell walls (Lu et al., 2008).

TLR4 is the only family member that can be

internalized from the plasma membrane or remain at the plasma membrane after binding
to lipopolysaccharide, and thus has the ability to induce two different intracellular
signaling cascades, one from each of the two locations (Owen et al., 2013). If TLR4 binds to
LPS at the plasma membrane, the MyD88 (Myeloid differentiation factor 88) signaling
pathway is used (Owen et al., 2013). If TLR4 is internalized in an endosome, the TRIF (TIRdomain-containing adaptor-inducing IFN-beta factor) signaling pathway is used (Owen et
al., 2013). The transcription factor NF-kappaB is activated via both the MyD88 and TRIF
signaling pathways and initiates the transcription of pro-inflammatory cytokines. These
cytokine proteins function as part of the innate immune system.
TLR proteins form protein complexes via their extracellular domains that function
in the recognition of and binding to their specific ligands. TLR4 forms a complex with
CD14 and MD2 via its extracellular domain (Parham, 2015). CD14 transfers
lipopolysaccharide to the TLR4 extracellular domain (Parham, 2015). This transfer is then
recognized by MD-2, which allows for the protein to dimerize and subsequently induce
signaling (Parham, 2015). TLRs have unique associated signaling pathways determined by
the TLR region (TIR domain) and the associated adaptor protein involved in the TLR
cytoplasmic domain complex (Owen et al., 2013). When members of the TLR family
dimerize after binding to their ligand, TIR domains change conformation and bind to the
specific adaptor protein that will be associated with that particular TLR cytoplasmic
domain, which activates the appropriate signaling cascades specific to the associated
adaptor protein (Figure 1.5). Two of these key adaptors are MyD88 and TRIF (reviewed by
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Figure 1.5 TLR4 signaling. Intracellular signaling through the MyD88 pathway in response
to activation of TLR4 by LPS (Parham, 2015).
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Kawasaki et al., 2014). Most TLRs (especially those involved in bacterial recognition) bind
to the adaptor MyD88 to initiate MyD88-dependent signaling pathways (reviewed by
Kawasaki et al., 2014). TLR4 has the unique ability to bind to both MyD88 and TRIF
adaptor proteins and initiate both MyD88 and TRIF-dependent signaling pathways
(reviewed by Kawasaki et al., 2014). TLR4 binds MyD88 when it is embedded in the
plasma membrane or binds TRIF when it is located within endosomes following
internalization (Zanoni et al., 2011).

Two other adaptors are necessary for proper

functioning of the TLRs and include TIRAP (TIR-domain containing adaptor protein) and
TRAM (TRIF-related adaptor molecule; Parham, 2015). Both are adaptor proteins that
recruit either MyD88 (TIRAP) or TRIF (TRAM), depending on where the TLR protein is
located. Thus, TIRAP and TRAM dictate which signaling pathway is utilized in addition to
the receptor location.
The TLR4 protein is expressed on the surface of immune cells of both myeloid and
lymphoid subsets, including monocytes, macrophages, and dendritic cells (both mature
and immature) in mice (Vaure and Liu, 2014). TLR4 is expressed exclusively by microglia
in mouse brain and is also expressed in mouse heart, kidney, liver, lung, pancreas, smooth
muscle, and spleen (Vaure and Liu, 2014). TLR4 had greater expression in mouse heart
and lung compared to other mouse organs (Vaure and Liu, 2014). In rats, TLR4 is detected
in individuals with normal blood pressure but is upregulated in individuals with
hypertension, suggesting that it may play a role in cardiovascular disorders (Eissler et al.,
2011; Figure 1.6). This upregulation was reversed when the hypertension was reduced
with a dose of Ramipril (Eissler et al., 2011).
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Figure 1.6 TLR4 is expressed in rodent cardiomyocytes and is upregulated in response to
hypertension. Immunohistochemistry showing expression of TLR4 in rat cardiomyocytes.
A. TLR4 was detected in control rats that were normotensive (WKY). B. Rats that
experienced hypertension (SHR) showed an upregulation of TLR4 in cardiomyocytes
compared to normotensive rats. C. Ramipril was given as a treatment to reduce
hypertension in SHR rats simultaneously reversing TLR4 upregulation (Eissler et al.,
2011).
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In the retina, TLRs were characterized as fully functional receptors with the
capability to induce an innate immune response following stimulation with pathogenic
ligands in a 661W photoreceptor cell line (Singh and Kumar, 2015). In that study, TLRs
were localized to both Müller glial cells and photoreceptor cells (Singh and Kumar, 2015).
In 2014, Jeong et al. reported that Basigin influenced the signaling pathways
mediated by accessory proteins MyD88 and TRIF. Basigin was linked to NF-kappaB
activation via both MyD88 and TRIF pathways, in that signaling occurred in the presence of
Basigin, but when Basigin was knocked down, signaling was decreased by about 85
percent (Jeong et al., 2014). The same study indicated that when an antibody specific for
Basigin was applied, signaling was also decreased by about 40 percent (Jeong et al., 2014).
Although the MyD88 signaling pathway is commonly induced by most of the TLRs in
response to ligand binding, the only member of the TLR family that has the ability to
induce signaling through both MyD88 and TRIF signaling pathways is TLR4.
Despite the influential nature of the Basigin protein in the pro-inflammatory
signaling cascades associated with MyD88 and TRIF pathways, Basigin has not been shown
to directly interact with the TLR4 protein. Both Basigin and TLR4 are expressed by many
of the same tissues in mice (Ochrietor et al., 2003, Eissler et al., 2011). The TLR4 protein
forms extensive complexes with other proteins via both the extracellular and cytoplasmic
domains to induce signaling in response to the recognition of LPS.
The purpose of this study is to determine if an interaction exists between Basigin
and TLR4 and to determine which amino acid residues in the Basigin transmembrane
domain may be important for stabilizing the interaction. It is hypothesized that Basigin
will interact with TLR4 and that the charged glutamate residue within the Basigin
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transmembrane domain will be important for stabilizing the interaction. Investigating
these aspects of immune-mediated pro-inflammatory signaling events will collectively
increase the understanding of the interactions that occur at the cellular level during the
process of inflammation. Understanding the role that Basigin plays in TLR4 signaling
pathways and how it is connected to the development of inflammation through TLR4 could
be crucial for a better understanding of how these processes occur.
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Chapter 2 - Methods
Expression plasmids
Expression plasmids containing the cDNA for the entire Basigin transmembrane
domain (pET102-BasTM-all), as well as the truncated portions of the domain (pET102BasTM-1-6, pET102-BasTM-7-12, pET102-BasTM-13-18, and pET102-BasTM-19-24) were
generated previously (Finch et al., 2009). In addition, the plasmid containing the cDNA for
the entire Basigin transmembrane domain with the coding sequence for glutamate
mutated to glycine (pET102-BasTM-all-E13G) and the plasmids in which the coding
sequences for the individual amino acids are each mutated to glycine (pET102-BasTM-1-6M1G, pET102-BasTM-1-6-A2G, pET102-BasTM1-6-A3G, pET102-BasTM1-6-L4G; pET102BasTM1-6-W5G, and pET102-BasTM-1-6-P5G) were previously generated (Finch et al.,
2009). For these plasmids, the cDNA was cloned into the bacterial expression plasmid
pET102 (Invitrogen Corporation, Carlsbad, CA). This plasmid allows for recombinant
protein expression using BL21 cells (Invitrogen Corporation) in which the protein product
contains six histidines at the carboxy-terminus. The plasmid codes for 157 amino acids,
which allows the six to 24 amino acids of the hydrophobic transmembrane domain to be
expressed as soluble proteins (Finch et al., 2009).

Site Directed Mutagenesis
For mutation of the coding sequences of individual amino acids within the pET102BasTM 7-12 and pET102 BasTM 13-18 plasmids, 1 μl dNTP mix, 1 μl pET102 BasTM 7-12
plasmid DNA or pET102 BasTM 13-18 plasmid DNA (Finch et al., 2009), 5 μl 10X Buffer, 1
μl forward primer (Table 2.1), 1 μl reverse primer (Table 2.1), and 3 μL Quick Solution
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Table 2.1 Basigin transmembrane domain mutagenesis primers

Primer

Sequence

BasTM 7-12 F7G F

5’-GGGAATTGATCCCTTCACCGGCCTAGGCATCGTGGCTAAG

BasTM 7-12 F7G RV

5’-CTTAGCCACGATGCCTAGGCCGGTGAAGGGATCAATTCCC

BasTM 7-12 L8G F

5’-GAATTGATCCCTTCACCTTCGGGGGCATCGTGGCTAAGGGCGAG

BasTM 7-12 L8G RV

5’-CTCGCCCTTAGCCACGATGCCCCCGAAGGTGAAGGGATCAATTC

BasTM 7-12 I10G F

5’-CCCTTCACCTTCCTAGGCGGGGTGGCTAAGGGCGAGCTC

BasTM 7-12 I10G RV

5’-GAGCTCGCCCTTAGCCACCCCGCCTAGGAAGGTGAAGGG

BasTM 7-12 V11G F

5’-CCTTCCTAGGCATCGGCGCTAAGGGCGAGCTC

BasTM 7-12 V11G RV

5’-GAGCTCGCCCTTAGGCCCGATGCCTAGGAAGG

BasTM 7-12 A12G F

5’-CTTCCTAGGCATCGTGGGGAAGGGCGAGCTCAAGC

BasTM 7-12 A12G RV

5’-GCTTGAGCTCGCCCTTCCCCCACGATGCCTAGGAAG

BasTM 13-18 E13G F

5’-GGAATTGATCCCTTCACCGGGGTCCTGGTGTTGGTTAAG

BasTM 13-18 E13G RV

5’-CTTAACCAACACCAGGACCCCGGTGAAGGGATCAATTCC

BasTM 13-18 V14G F

5’-GAATTGATCCCTTCACCGAGGGCCTGGTGTTGGTTAAGGGCGAG

BasTM 13-18 V14G RV

5’-CTCGCCCTTAACCAACACCAGGCCCTCGGTGAAGGGATCAATTC

BasTM 13-18 L15G F

5’-CCTTCACCGAGGTCGGGGTGTTGGTTAAGG

BasTM 13-18 L15G RV

5’-CCTTAACCAACACCCCGACCTCGGTGAAGG

BasTM 13-18 V16G F

5’-CTTCACCGAGGTCCTGGGGTTGGTTAAGGGCGAG

BasTM 13-18 V16G RV

5’-CTCGCCCTTAACCAACCCCAGGACCTCGGTGAAG

BasTM 13-18 L17G F

5’-CACCGAGGTCCTGGTGGGGGTTAAGGGCGAGCTC

BasTM 13-18 L17G RV

5’-GAGCTCGCCCTTAACCCCCACCAGGACCTCGGTG

BasTM 13-18 V18G F
BasTM 13-18 V18G RV

5’-CGAGGTCCTGGTGTTGGGGAAGGGCGAGCTCAAGC
5’-GCTTGAGCTCGCCCTTCCCCAACACCAGGACCTCG
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(QuickChange® II XL Site Directed Mutagenesis Kit, Stratagene, La Jolla, CA) were
combined in a final volume of 50 μl.

One microliter of PfuUltra™ high-fidelity DNA

Polymerase (Stratagene) was added and the solution was subjected to thermal cycling in
which the following cycling parameters were utilized: 95°C for 1 minute followed by 18
cycles of 95°C for 50 seconds, 60°C for 50 seconds, 68°C for 5 minutes and finally 1 cycle of
68°C for 7 minutes. A restriction digest was performed in which 1 μl of the restriction
enzyme Dpn I was added to each reaction sample followed by incubation at 37°C for 1
hour.
The resulting plasmids were then transformed into bacterial cells. Two microliters
of the appropriate plasmid DNA were added into 50 μl XL10-Gold® Ultracompetent cells
(Strategene). The solution was incubated on ice for 20 minutes followed by incubation at
42°C for 30 seconds. Two hundred fifty microliters SOC broth was added and the cells
were incubated at 37°C for 1 hour with shaking. The contents of the solution were
transferred to an LB agar plate containing carbenicillin (50 μg/mL) and incubated at 37°C
overnight.
Selected colonies of XL10-Gold® Ultracompetent cells (Strategene) were isolated
from the LB agar plate and added to 3 mL LB broth. The solution was incubated overnight
at 37°C with shaking.
Plasmids were purified using the QIAprep miniprep protocol (QIAGEN Corporation,
Valencia, CA).

One thousand five hundred microliters of culture (from each culture

incubated overnight) was centrifuged at 13,000 rpm for 1 minute. Two hundred fifty
microliters buffer P1 (QIAprep® Miniprep, Qiagen) were added to resuspend the pelleted
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bacterial cells, followed by the addition of 250μL buffer P2. The tubes were inverted 6
times, followed by the addition of 350μL buffer N3. The tubes were inverted 6 times,
followed by centrifugation at 13,000 rpm for 10 minutes. Supernatants were applied to
spin columns, followed by centrifugation at 13,000 rpm for 1 minute. The flow-through
was discarded and 500μL buffer PB was applied to the spin columns. The spin columns
were centrifuged at 13,000 rpm for 1 minute and the flow-through was discarded. Seven
hundred fifty microliters buffer PE were applied to the spin columns, followed by
centrifugation at 13,000 rpm for 1 minute. The flow-through was discarded and the spin
columns were centrifuged once again in the absence of buffer at 13,000 rpm for 1 minute.
Fifty microliters buffer EB were applied to the spin columns, followed by incubation at
room temperature for 1 minute and subsequent centrifugation at 13,000 rpm for 1 minute.
The flow-through containing eluted plasmid DNA was saved.
Sequences were verified by the Operon-Eurofin Corporation (Louisville, KY) and
subsequently analyzed using the ExPASy Bioinformatics Research Portal maintained by the
Swiss Institute of Bioinformatics (web.expasy.org/translate).

Recombinant Protein Expression and Purification
Two microliters of appropriate plasmid were added into 50μL of BL21 E.coli cells
(Invitrogen Corporation, Carlsbad, CA). The solution was incubated on ice for 20 minutes
followed by incubation at 42°C for 30 seconds. Two hundred fifty microliters of SOC broth
was added and the cells were incubated at 37°C for 1 hour with shaking. The cells were
transferred to 10 mL LB broth containing carbenicillin (50 μg/mL) and incubated at 37°C
overnight with shaking. The entire overnight culture containing plasmid was added to 250

20

mL LB broth containing carbenicillin (50 μg/mL) and incubated for 3 hours at 37°C with
shaking.

Two hundred fifty microliters of 1M IPTG was added and the culture was

incubated overnight at 37°C with shaking.
For purification, two hundred fifty milliliters of overnight culture were centrifuged
at 3,000 rpm for 15 minutes. Pelleted bacterial cells were re-suspended in 10 mL Talon
Xtractor buffer (Clontech, Mountain View, CA) in addition to lysozyme (100 microliters of
10 mg/mL) and DNase I (20 microliters) and the solution was incubated for 10 minutes at
room temperature. The solution was centrifuged for 20 minutes at 10,000 rpm to form a
protein lysate. The protein lysate was then applied to Talon metal affinity resin (Clontech)
and purified via affinity chromatography. Protein was collected in 0.5 mL fractions and the
content was analyzed at 280 nm.
Protein concentration was determined using the Bradford Coomassie protein assay
(Pierce Biotechnology, Rockford, IL, USA). A standard curve was generated by using serial
dilutions of bovine serum albumin (BSA) from 0.2 mg/mL to 2.0 mg/mL. Five microliters
of each BSA dilution was transferred to the wells of a 96 well plate in addition to 5
microliters of recombinant protein fractions. Absorbance at 595 nm was measured using
a Bio-Tek plate reader (Biotek Instruments, Winooski, VT) and the average absorbance
was obtained for each duplicate BSA dilution. The averages were used to generate a graph
in which the y-axis was labeled absorbance at 595 nm and the x-axis was labeled protein
concentration in mg/mL. An equation was obtained from the logarithmic regression of the
average BSA dilution absorbance values and the unknown recombinant protein
concentrations were determined from the equation.
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Mouse Tissue Protein Lysates
Mice were sacrificed according to accepted protocols and tissue (retina, brain, or
heart) was removed and immediately placed into 2 mL PBS. The tissue was homogenized
and the protein concentration was determined via the Bradford Coomassie protein assay
previously described.

Enzyme-Linked Immunosorbent Assay (ELISA)
One hundred microliters of anti-TLR4 capture antibody (Pierce/Thermo Scientific;
0.05 μl antibody/100 μl PBS) was added to wells of a 96 well plate. Several wells received
100 microliters of PBS and no antibody.

The plate was incubated at 4°C overnight.

Unbound capture antibody was removed followed by three washes with approximately
200 μl PBS-Tween (PBS-T). One hundred microliters of bovine serum albumin (BSA;
Pierce/ThermoScientific, Rockford, IL; diluted 1:10 in PBS) was added to wells of the plate.
The plate was incubated at 37°C for 30 minutes. The BSA was removed from the wells and
they were washed three times with approximately 200 μl PBS-T. One hundred microliters
of endogenous proteins from mouse heart (diluted to 100 μg/mL in PBS) were added to
wells of the plate. The plate was incubated at 37°C for 30 minutes. Unbound mouse heart
proteins were removed and the wells were washed three times with approximately 200 μl
PBS-T. One hundred microliters of the appropriate recombinant protein were added to
wells of the plate. The plate was incubated at 37°C for 30 minutes. Unbound recombinant
proteins were removed and the wells were washed three times with approximately 200 μl
PBS-T. One hundred microliters of anti-6x-His primary antibody (diluted 1:1000 in PBS)
was added to wells of the plate. The plate was incubated at 37°C for 30 minutes. Unbound
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primary antibody was removed and the wells were washed three times with
approximately 200 μl PBS-T. One hundred microliters of alkaline phosphatase-conjugated
goat-anti-mouse secondary antibody (AP-GAM; Pierce/ThermoScientific; diluted 1:1000 in
PBS) was added to wells of the plate. The plate was incubated at 37°C for 30 minutes.
Unbound secondary antibody was removed and the wells were washed three times with
approximately 200 μl PBS-T. One hundred microliters of AP substrate (PNPP; Thermo
Fisher Scientific, Rockford, IL) was added to wells of the plate. The reactions were stopped
by the addition of 50 μl 2N NaOH to all wells. The absorbance in each well was measured
at 405 nm on a Bio-Tek plate reader (Biotek Instruments, Winooski, VT)
To detect the presence of TLR4 and Basigin in mouse heart, one hundred
microliters of endogenous proteins from mouse heart (diluted to 100 μg/mL in PBS) were
added to wells of the plate. The plate was incubated at 4°C overnight. Unbound mouse
heart proteins were removed. One hundred microliters of either anti-TLR4 antibody
(Pierce/Thermo Scientific) or anti-Basigin antibody (Ochrietor et al., 2003; 0.05 μl
antibody/100 μl PBS) were added. The plate was incubated at 37°C for 30 minutes.
Unbound antibody was removed and the wells were washed three times with
approximately 200 μl PBS-T. One hundred microliters of the appropriate alkaline
phosphatase conjugated secondary antibody (AP-GAM or AP-GAR; Pierce/Thermo
Scientific; diluted 1:1000 in PBS) was applied to the wells, followed by an incubation at
37°C for 30 minutes. Unbound secondary antibody was removed and the wells were
washed three times with approximately 200 μl PBS-T. One hundred microliters of AP
substrate (PNPP; Thermo Fisher Scientific) was added to wells of the plate. The reactions
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were stopped by the addition of 50 μl 2N NaOH to all wells. Absorbance in each well was
measured at 405 nm using a Bio-Tek plate reader.
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Chapter 3 - Results
The aim of the present study was to investigate the relationship between the
Basigin transmembrane domain and TLR4. To achieve this aim, binding assays were
employed to determine if the transmembrane domain of Basigin physically interacts with
TLR4. Expression plasmids containing the cDNA for the entire transmembrane domain of
Basigin gene products, or truncated portions of the domain, cloned in frame of a six
histidine carboxy-terminal epitope tag were previously generated (Finch et al., 2009) and
used in the present study.

Recombinant protein expression was achieved by

transformation of BL21 cells (Invitrogen Corporation), followed by the induction of protein
synthesis and protein purification via affinity chromatography.

Although the

transmembrane domain sequence for Basigin is highly hydrophobic, a soluble recombinant
protein is generated, because the vector codes for 157 amino acids that mask the
hydrophobic nature of that sequence (Finch et al., 2009).
To effectively utilize the recombinant Basigin transmembrane domain proteins in
ELISA binding assays, it was necessary to find a suitable tissue to serve as a source of
endogenous TLR4 protein. Reports indicate that TLR4 is expressed by microglia of the
brain, in heart, lung, liver, pancreas, smooth muscle, spleen, and immune cells such as
monocytes, macrophages, and dendritic cells, with highest expression in mouse heart and
lung (Vaure and Liu, 2014). Additionally, TLR4 has previously been reported to be
expressed in retinal cell types such as photoreceptors and Müller glial cells (Singh and
Kumar, 2015; Kumar and Shamsuddin, 2012). Therefore, mouse retinas were isolated,
homogenized and subjected to an ELISA to detect the presence of endogenous TLR4. The
results of that initial ELISA analysis indicated that endogenous TLR4 is not detectable in
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mouse retina. No significant difference in TLR4 expression was observed between the
retina lysates and bovine serum albumin (BSA), the negative control (p-value = 0.338;
Figure 3.1A). Similarly, data from ELISA analyses conducted using mouse brain also
demonstrate that TLR4 is not detectable in that tissue (Figure 3.1B). An ELISA analysis
was next performed using mouse heart. TLR4 expression was detected in mouse heart at a
level significantly greater than that of the BSA negative control (p value = 0.006; Figure
3.1C). The subsequent analyses to investigate the Basigin-TLR4 interaction used mouse
heart as a source for TLR4.
In addition, it was necessary to demonstrate that Basigin is also expressed within
mouse heart samples. Therefore, an ELISA was performed to assay for the expression of
endogenous Basigin in mouse heart. It was determined that Basigin is indeed expressed in
mouse heart, as the levels were significantly greater than those of the BSA negative control
(p value = 1.205 x 10-5; Figure 3.2).
Once an appropriate source of TLR4 protein was determined, ELISA binding assays
were performed to assess the ability of the Basigin transmembrane domain to bind TLR4.
The recombinant Basigin protein consisting of the entire transmembrane domain was first
used in an ELISA with endogenous mouse heart TLR4. The results indicate that the Basigin
transmembrane domain does interact with TLR4 at a level that is significantly greater (pvalue = 9.17 x 10-5) than that of the control recombinant protein, which consists of vectorspecific amino acids (Figure 3.3). To determine whether the glutamate residue within the
Basigin transmembrane domain is used in the interaction with TLR4, a recombinant
Basigin transmembrane domain protein in which the transmembrane glutamate (E)
residue was mutated to glycine (G) via site-directed mutagenesis was also used in an
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Figure 3.1. TLR4 is present in mouse heart and was not detected in retina or brain. Wells
were coated with either retina lysates (A), brain lysate (B), or heart lysate (C) and bovine
serum albumin (BSA) at 100 g/mL. An antibody specific for the TLR4 protein (Pierce/
Thermo Scientific) was applied directly to the immobilized proteins and an alkaline
phosphatase-conjugated goat anti-rabbit (AP-GAR) antibody was subsequently applied
(Pierce/Thermo Scientific). Binding was measured using an alkaline phosphatase
detection system and spectrophotometric analysis at 405 nm. Error bars represent
standard deviations of the mean. A Student’s T test was performed to compare detection
of TLR4 in retina to the negative control (BSA). * indicates a p-value of less than 0.05.
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Figure 3.2. Basigin is present in mouse heart. Wells were coated with mouse heart
proteins or bovine serum albumin (BSA) at 100 g/mL. An antibody specific for the
Basigin protein (Ochrietor et al., 2003) was applied directly to the proteins and an alkaline
phosphatase-conjugated goat anti-mouse (AP-GAM) antibody (Pierce/Thermo Scientific)
was subsequently applied. Binding was measured using an alkaline phosphatase detection
system and subsequent spectrophotometric analysis at 405 nm. Error bars represent
standard deviations of the mean. A Student’s T test was performed to compare detection of
Basigin in mouse heart to the negative control (BSA). * indicates a p-value of less than 0.05.
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ELISA. The assay specifically tested whether the absence of the glutamate would result in
decreased binding between Basigin and TLR4. The results indicate that the glutamate
residue alone does not appear to be essential for the interaction with TLR4 because
binding of the mutated transmembrane domain to TLR4 was not significantly lower than
that of the non-mutated transmembrane domain (p value comparing binding of the normal
and mutated Basigin proteins = 0.106; Figure 3.3). The p values comparing binding of
either normal Basigin or mutated Basigin to the control protein were less than 0.05 in both
cases (Figure 3.3).
The affinity of each recombinant protein for TLR4 was also assessed via ELISA
analyses. It was determined that the affinity of the transmembrane domain of Basigin for
TLR4 is moderate at 0.742 M and is similar to affinities for antibody-antigen interactions
in the human immune system (Parham, 2015; Figure 3.4). The transmembrane domain of
Basigin with the glutamate mutation to glycine had a similar affinity (p value = 0.103) at
0.930 M (Figure 3.5).
To better understand what segments of the Basigin transmembrane domain were
important for the interaction between Basigin and TLR4, recombinant Basigin proteins
consisting of various segments of the transmembrane were generated (Finch et al., 2009)
and used in ELISA analyses. Figure 3.6 indicates that amino acid residues 7-12 (p value =
0.00013), 13-18 (p value = 0.0201), and 19-24 (p value = 3.55 x 10-5) are the most essential
for establishing the interaction with TLR4 (Figure 3.6). The binding affinity of each of the
Basigin recombinant proteins for TLR4 is as follows: BasTM 1-6 6XHis binding affinity =
0.097 M (Figure 3.7 A); BasTM 7-18 6XHis binding affinity = 0.144 M (Figure 3.7 B);
BasTM 19-24 6XHis binding affinity = 0.236 M (Figure 3.7 C); BasTM 7-12 6XHis binding
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Figure 3.3. The Basigin transmembrane domain binds to TLR4. The TLR4 protein was
captured from mouse heart lysates using an antibody specific for TLR4 (Pierce/Thermo
Scientific). The appropriate recombinant Basigin proteins were applied (BasTM or BasTM
E13G) and a primary antibody specific for the six histidine tag (BD Biosciences) present on
the recombinant proteins was applied. An alkaline phosphatase-conjugated goat antimouse (AP-GAM) antibody (Pierce/Thermo Scientific) was added and binding was
measured using an alkaline phosphatase detection system and spectrophotometric analysis
at 405 nm. The control consisted of 157 amino acid residues encoded by the pET102
plasmid. Error bars represent standard deviations of the mean. A Student’s T test was
performed to compare binding of each recombinant Basigin protein to TLR4 with that of
the control recombinant protein. * indicates a p-value of less than 0.05.
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Figure 3.4. A binding affinity assay for Basigin transmembrane domain binding to TLR4.
Endogenous TLR4 was captured and incubated with recombinant Basigin transmembrane
domain (BasTM) at 0.5, 1.0, 1.5, 2.5, and 5.0 M. Binding between endogenous TLR4 and
the recombinant Basigin protein was measured using an alkaline phosphatase detection
system and spectrophotometric assay at 405 nm. Percent binding was calculated for each
concentration and the binding affinity of the recombinant Basigin protein for TLR4 was
determined from the slope equation. All runs were performed in triplicate. Error bars
represent standard deviations of the mean.
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Figure 3.5. A binding affinity assay for BasTM E13G binding to TLR4. Endogenous TLR4
was captured and incubated with recombinant Basigin transmembrane domain in which
the glutamate residue was mutated (BasTM E13G) at 0.5, 1.0, 1.5, 2.5, and 5.0 M. Binding
between endogenous TLR4 and the recombinant Basigin protein was measured using an
alkaline phosphatase detection system and spectrophotometric assay at 405 nm. Percent
binding was calculated for each concentration and the binding affinity of the mutated
recombinant Basigin protein for TLR4 was determined using the slope equation. All runs
were performed in triplicate. A Student’s T-Test was used to compare the mutated
transmembrane binding affinity to that of the normal Basigin transmembrane domain. A
p-value of less than 0.05 is considered statistically significant. Error bars represent
standard deviations of the mean.
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Figure 3.6. Basigin transmembrane segments 7-12, 13-18, and 19-24 bind to TLR4.
Endogenous TLR4 was captured using an antibody specific to TLR4 (Pierce/Thermo
Scientific) and was incubated with the appropriate recombinant Basigin protein (BasTM 16 6XHis, BasTM 7-12 6XHis, BasTM 13-18 6XHis, and BasTM 19-24 6XHis) followed by the
application of a primary antibody specific for the six histidine tag (BD Biosciences). An
alkaline phosphatase-conjugated goat anti-mouse (AP-GAM) antibody (Pierce/Thermo
Scientific) was applied. Binding was measured using an alkaline phosphatase detection
system and spectrophotometric analysis at 405 nm. The control consisted of 157 amino
acid residues encoded by the pET102 plasmid. Error bars represent standard deviations of
the mean. A Student’s T test was performed to compare binding of Basigin transmembrane
segments to TLR4 in mouse heart to that of the control protein. * indicates a p-value of less
than 0.05.
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Figure 3.7. Binding affinity assays for BasTM segment binding to TLR4. Endogenous TLR4
was captured and incubated with recombinant Basigin transmembrane domain segments
(BasTM 1-6 [A], BasTM 7-18 [B], BasTM 7-12 [C], BasTM 13-18 [D], BasTM 19-24[E]) at
0.5, 1.0, 1.5, 2.5, and 5.0 M. Binding between endogenous TLR4 and the recombinant
Basigin protein was measured using an alkaline phosphatase detection system and
spectrophotometric assay at 405 nm. Percent binding was calculated for each
concentration and the binding affinity of the recombinant Basigin protein for TLR4 was
determined from the slope equation. All runs were performed in triplicate. Error bars
represent standard deviations of the mean.
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affinity = 0.109 M (Figure 3.7 D); BasTM 13-18 6XHis binding affinity = 0.160 M (Figure
3.7 E). Binding affinities of all recombinant Basigin transmembrane segments for TLR4
were compared to the normal Basigin transmembrane domain containing all 24 amino acid
residues using standard deviation and the Student’s T Test (Table 3.1).
Based on the binding affinity comparison of each Basigin transmembrane segment,
Basigin transmembrane residues 1-6 (BasTM 1-6 6XHis), 7-12 (BasTM 7-12 6XHis), and
13-18 (BasTM 13-18 6XHis) have the highest affinity for TLR4 and binding affinities of
these segments are significantly greater than the binding affinity of Basigin
transmembrane residues 19-24 (BasTM 19-24 6XHis). For each of these Basigin
transmembrane segments, individual consecutive amino acids within the segment were
mutated to glycine (G) via site-directed mutagenesis and recombinant proteins were
generated for each of the amino acids that were mutated within that Basigin
transmembrane segment. All of the recombinant proteins subsequently generated
containing these mutations were used in ELISA analyses to determine which specific amino
acids within those segments are important for the interaction with TLR4. All mutated
recombinant proteins were compared to the appropriate normal recombinant Basigin
protein segment (Figures 3.8, 3.9, and 3.10). BasTM 1-6 was compared to recombinant
proteins containing mutations for each consecutive amino acid within that segment (Finch
et al., 2009; Figure 3.8). The methionine at position 1, alanine at position 2, and alanine at
position 3 within the Basigin 1-6 transmembrane segment appear to be essential for the
interaction with TLR4 (BasTM 1-6 M1G p-value = 0.03; BasTM 1-6 A2G p-value = 0.01;
BasTM 1-6 A3G p-value = 0.02). The leucine at position 4, tryptophan at position 5, and
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Table 3.1. Comparison of Basigin transmembrane segment binding affinities for TLR4.
Statistical analyses were performed to compare the binding affinities of BasTM and BasTM
segments for TLR4 using three distinct mouse hearts. Average values were calculated for
each protein construct and the percent binding was determined. The concentration at
which the percent binding of the recombinant Basigin protein was 50% was calculated.
The calculated binding affinities of each recombinant protein were compared using a
Student’s T-test to obtain a p-value. The standard deviation was calculated for binding
affinities from each mouse heart.

Construct

Affinity

p-value

BasTM 6XHis

0.742 μM ± 0.162

BasTM E13G 6XHis

0.930 μM ± 0.044

0.103

BasTM 1-6 6XHis

0.097 μM ± 0.011

0.012

BasTM 19-24 6XHis

2.289 μM ± 0.200

0.002

BasTM 7-12 6XHis

0.109 μM ± 0.006

0.011

BasTM 13-18 6XHis

0.160 μM ± 0.012

0.013
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Figure 3.8. ELISA analysis comparing BasTM 1-6 binding to TLR4 to that of recombinant
proteins containing consecutive amino acid substitutions to glycine (G) within the BasTM
1-6 segment. An antibody specific for the TLR4 protein was plated followed by an
application of mouse heart lysate. The appropriate recombinant Basigin proteins were
applied (BasTM 1-6 M1G 6XHis, BasTM 1-6 A2G 6XHis, BasTM 1-6 A3G 6XHis, BasTM 1-6
L4G 6XHis, BasTM 1-6 W5G 6XHis, and BasTM 1-6 P6G 6XHis) and a primary antibody
specific for the six histidine tag was applied. An alkaline phosphatase-conjugated goat antimouse (AP-GAM) antibody was subsequently applied. Binding was measured using an
alkaline phosphatase detection system and subsequent spectrophotometric analysis at 405
nm. Error bars represent standard deviations of the mean. A Student’s T test was
performed to compare binding of Basigin transmembrane segments to TLR4 in mouse
heart to the control protein. * indicates a p-value of less than 0.05.
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proline at position 6 within the Basigin 1-6 transmembrane segment do not appear to be
essential for the interaction with TLR4 because when mutated, they did not show a
significant difference in the ability of BasTM 1-6 to bind to TLR4 than the normal Basigin 16 transmembrane segment (BasTM 1-6 L4G p-value = 0.42; BasTM1-6 W5G p-value = 0.18;
BasTM 1-6 P6G p-value = 0.11).
The BasTM 7-12 recombinant protein was compared to recombinant proteins
containing mutations for each consecutive amino acid within that segment (Figure 3.9).
The phenylalanine residue at position 7, the leucine residue at position 8, and the valine
residue at position 11 appear to be important for the interaction with TLR4 (BasTM 7-12
F7G 6XHis p-value = 0.019; BasTM 7-12 L8G 6XHis p-value = 0.033; BasTM 7-12 V11G
6XHis p-value = 0.025). The isoleucine residue at position 10 and alanine residue at
position 12 within the Basigin 7-12 transmembrane segment do not appear to be essential
for the interaction between Basigin and TLR4 because when mutated, there was no
significant difference in the ability of BasTM 7-12 to bind to TLR4 than the normal Basigin
7-12 transmembrane segment (BasTM 7-12 I10G 6XHis p-value = 0.37; BasTM 7-12 A12G
6XHis p-value = 0.28).
The BasTM 13-18 recombinant protein was compared to recombinant proteins
containing mutations for each consecutive amino acid within that transmembrane segment
(Figure 3.10). The glutamate residue at position 13, valine residues at position 14 and 16,
and leucine residues at position 15 and 17 are important for the interaction with TLR4
(BasTM 13-18 E13G 6XHis p-value = 0.001; BasTM 13-18 V14G 6XHis p-value = 0.017;
BasTM 13-18 L15G 6XHis p-value = 0.007; BasTM 13-18 V16G 6XHis p-value = 0.001;
BasTM 13-18 L17G p-value = 0.0007). Residue 18 within the Basigin transmembrane
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Figure 3.9. ELISA analysis comparing BasTM 7-12 binding to TLR4 to that of recombinant
proteins containing consecutive amino acid substitutions to glycine (G) within the BasTM
7-12 segment. An antibody specific for the TLR4 protein was plated followed by an
application of mouse heart lysate. The appropriate recombinant Basigin proteins were
applied (BasTM 7-12 F7G 6XHis, BasTM 7-12 L8G 6XHis, BasTM 7-12 I10G 6XHis, BasTM 712 V11G 6XHis, BasTM 7-12 A12G 6XHis, and BasTM 7-12 6XHis) and a primary antibody
specific for the six histidine tag was applied. An alkaline phosphatase-conjugated goat antimouse (AP-GAM) antibody was subsequently applied. Binding was measured using an
alkaline phosphatase detection system and subsequent spectrophotometric analysis at 405
nm. Error bars represent standard deviations of the mean. A Student’s T test was
performed to compare binding of Basigin transmembrane segments to TLR4 in mouse
heart to the control protein. * indicates a p-value of less than 0.05.
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Figure 3.10. ELISA analysis comparing BasTM 13-18 binding to TLR4 to that of
recombinant proteins containing consecutive amino acid substitutions to glycine (G) within
the BasTM 13-18 segment. An antibody specific for the TLR4 protein was plated followed
by an application of mouse heart lysate. The appropriate recombinant Basigin proteins
were applied (BasTM 13-18 E13G 6XHis, BasTM 1318 V14G 6XHis, BasTM 13-18 L15G
6XHis, BasTM 13-18 V16G 6XHis, BasTM 13-18 L17G 6XHis, and BasTM 13-18 V18G 6XHis)
and a primary antibody specific for the six histidine tag was applied. An alkaline
phosphatase-conjugated goat anti-mouse (AP-GAM) antibody was subsequently applied.
Binding was measured using an alkaline phosphatase detection system and subsequent
spectrophotometric analysis at 405 nm. Error bars represent standard deviations of the
mean. A Student’s T test was performed to compare binding of Basigin transmembrane
segments to TLR4 in mouse heart to the control protein. * indicates a p-value of less than
0.05.
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segment 13-18 does not appear to be essential for the interaction between Basigin and
TLR4 because when mutated, there was no significant difference in the ability of BasTM
13-18 to bind to TLR4 than the normal Basigin 13-18 transmembrane segment (BasTM 1318 V18G 6XHis p-value = 0.46).
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Chapter 4 - Discussion
It has been demonstrated that Basigin has the ability to influence signaling through
both the MyD88 and TRIF pathways, both of which are utilized by TLR4 to induce proinflammatory signaling in response to LPS detection (Jeong et al., 2014). However, the
short Basigin cytoplasmic domain does not possess putative binding sites for MyD88 or
TRIF (J. Brown, personal observation).

In addition, in analyzing the Basigin

transmembrane domain sequence, it is questionable as to why a hydrophilic glutamate
residue would be located in the hydrophobic environment of the plasma membrane. It has
been hypothesized that Basigin interacts with TLR4, using the charged glutamate residue
within the transmembrane domain, to initiate MyD88 and TRIF signaling cascades via the
TLR4 protein. Therefore, the purpose of the present study was to determine if the Basigin
transmembrane domain interacts with TLR4, and if so to analyze which amino acid
residues are important for stabilizing the interaction.
ELISA binding analyses indicate that Basigin does interact with TLR4 via the
transmembrane domain. These analyses also indicate that when the glutamate residue in
the Basigin transmembrane domain is mutated, a slight decrease in binding is observed
although that decrease is not considered significantly different from binding of the normal
Basigin transmembrane domain.
Additional assays were performed to understand what amino acid residues in the
Basigin transmembrane domain are important for the interaction with TLR4. Initially, the
Basigin transmembrane domain was separated into segments consisting of six amino acid
residues each to determine what segments have a higher affinity for the TLR4 protein.
Site-directed mutagenesis was performed on the segments that had a high affinity for TLR4
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such that each consecutive amino acid residue within that segment was mutated to glycine.
These mutated transmembrane domains were then expressed as recombinant proteins
and utilized in ELISA analyses to determine which residues within the segments are
important for interacting with TLR4. The binding affinity of the Basigin transmembrane
domain for TLR4 is similar to affinities of antibody-antigen interactions in the human
immune system (Parham, 2015).

BasTM 1-6, BasTM 7-12, and BasTM 13-18 had the

highest affinity for TLR4, while BasTM 19-24 had a significantly lower affinity. The
transmembrane segments with a high affinity for TLR4 were investigated further to
determine what residues were important for stabilizing the interaction between Basigin
and TLR4.
Within the BasTM 1-6 segment, the methionine residue at position 1, and the
alanine residues at positions 2 and 3 all appear to be essential for interacting with TLR4.
Amino acid mutations to residues 4 through 6 did not significantly change the affinity of
the BasTM 1-6 segment for TLR4 and did not appear to be as important as residues 1-3 in
the Basigin 1-6 transmembrane segment.
Within the BasTM 7-12 segment, the phenylalanine residue at position 7, the
leucine residue at position 8, and the valine residue at position 11 appear to be important
for the interaction with TLR4 because mutating these residues significantly decreased
binding between Basigin and TLR4. The isoleucine residue at position 10 and alanine
residue at position 12 within the Basigin transmembrane segment 7-12 do not appear to
be essential for the interaction between Basigin and TLR4
Within the BasTM 13-18 segment, all of the residues including the glutamate at
position 13, the valine residues at positions 14 and 16, and the leucine residues at
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positions 15 and 17 appear to be important for the interaction with TLR4 because
mutating these residues resulted in a significant decrease in binding between Basigin and
TLR4. The valine at position 18 does not appear to be important for the interaction
between Basigin and TLR4.
Although the ELISA analysis conducted using only the normal Basigin
transmembrane domain and the transmembrane domain in which only the glutamate was
mutated showed that the glutamate was not important for stabilizing the interaction, that
data did show a slight decrease in binding even though it was not considered significantly
different. It appears that the glutamate residue is important for stabilizing the interaction
with TLR4, along with almost all of the additional hydrophobic residues within the 13-18
transmembrane segment.

It would be expected that if several residues are key for

stabilizing an interaction, then a single mutation to one of those residues would not result
in a large decrease in binding between the two proteins because the additional residues
that were not mutated are still contributing to stabilization. When the smaller segment
consisting of only amino acids 13-18 was used, a significant difference in binding was
observed, likely because the affinity of that region for TLR4 is much greater than that of the
entire transmembrane domain, and a single amino acid change was enough to destabilize
the interaction.
The data indicate that mutations throughout the Basigin transmembrane domain
produced pronounced decreases in binding to TLR4 and suggests that the Basigin-TLR4
interaction is stabilized by both hydrophilic and hydrophobic interactions.

The

transmembrane domain sequence of TLR4 contains hydrophobic amino acids, as well as
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two histidine residues (accession number NM_021297.3), which have the ability to interact
with and stabilize the glutamate residue within the Basigin transmembrane domain.
Unlike the Basigin-TLR4 interaction characterized in this study, Finch et al., 2009
showed that the glutamate residue in the Basigin transmembrane domain was not
important for establishing an interaction with monocarboxylate transporter 1 (MCT1), and
that the Basigin-MCT1 interaction was stabilized solely by hydrophobic interactions. The
data from the present study indicate that Basigin does utilize the transmembrane domain
glutamate residue to stabilize the interaction with TLR4, in addition to hydrophobic
residues. The same study by Finch et al. demonstrated that mutations within the Basigin
transmembrane region 19-24 produced dramatic decreases in binding between Basigin
and MCT1, while mutations within the Basigin transmembrane segment 1-6 produced less
dramatic decreases in binding to MCT1 (Finch et al., 2009). The data presented in this
study suggests that mutations within the Basigin transmembrane segment 1-6 produce
significant decreases in binding between Basigin and TLR4. In contrast to Finch et al.,
2009, the Basigin transmembrane segment 19-24 has a significantly lower affinity for
TLR4 compared to transmembrane segments 1-6, 7-12, and 13-18. Mutations within the
Basigin transmembrane segments 7-12 and 13-18 produced significant decreases in
binding between Basigin and TLR4, however, Finch et al., 2009 indicated that those same
transmembrane segments were not utilized in the interaction between Basigin and MCT1.
It is possible that the extracellular and cytoplasmic domains of Basigin, in addition
to the transmembrane domain, play a role in influencing signaling through the TLR4induced signaling pathways MyD88 and TRIF; however, the main purpose of the present
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study was to specifically investigate the role of the Basigin transmembrane domain in proinflammatory signaling pathways associated with TLR4.
The ability of Basigin to influence the MyD88 and TRIF signaling pathways could be
in response to ligand binding via the extracellular domain of the Basigin protein. Jeong et
al. demonstrated that when an antibody specific for the Basigin protein was applied to cell
cultures, signaling through both the MyD88 and TRIF pathways was significantly
decreased. It was specifically shown that the cultures in which the antibody was applied
had lower levels of the transcription factor NF-kappaB when compared to cultures in
which no antibody was applied (Jeong et al., 2014). It is well established that the TLR4
protein, in addition to the proteins MD2 and CD14, are responsible for the detection of LPS
via the formation of a complex with the extracellular domain of TLR4 (Owen et al., 2013).
It is not known if Basigin has the ability to interact with LPS or the proteins involved in
forming a complex with the extracellular or cytoplasmic domains of TLR4 during the
initiation of pro-inflammatory signaling pathways involving MyD88 and TRIF. Because
Basigin possesses a short cytoplasmic domain with no known putative binding sites for
MyD88 and TRIF, yet has been documented to elicit signal transduction events through
these pathways (Jeong et al., 2014), it is possible that the role of Basigin in proinflammatory signaling is to establish an interaction with TLR4 in response to binding of
yet to be identified ligand to carry out the signaling events. This is reminiscent of the
structure and activation process for the T cell receptor, which uses different proteins
within the receptor complex to bind ligand and to elicit signal transduction (Birnbaum et
al., 2014).
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It is known that Basigin is involved in the Wnt/beta-catenin pathway, a pathway
extensively involved in embryonic development that regulates cell proliferation and
migration (Wei et al., 2010; Logan and Nusse, 2004). The Wnt/beta-catenin pathway is
also a prevalent pathway associated with cancer (Reya and Clevers, 2005). It is well
understood that Basigin is highly expressed on the surface of tumors and serves as a cell
surface marker for the identification of some cancer cells (Davidson et al., 2003; Yan et al.,
2005). Unscheduled reactivation of the Wnt/beta-catenin pathway has the ability to cause
inflammatory diseases and it is known that both developmental signaling pathways and
inflammatory signaling pathways are used by metastatic cancer cells for the purpose of
proliferation and the ability to alter cell interactions (Morrisey, 2003; Srikrishna and
Freeze, 2009; Hagemann et al., 2005). The full role of Basigin in signaling through proinflammatory pathways is unknown, but it is intriguing to speculate that Basigin is
necessary for the overlapping of Wnt/beta-catenin and pro-inflammatory pathways
necessary for cancer cell proliferation. In non-cancer cells, Basigin may play a role in
initiating inflammation through TLR4 in response to LPS or another, yet to be identified
ligand.
In conclusion, the results of this study indicate that the Basigin and TLR4 proteins
interact and that this interaction via the Basigin transmembrane domain is stabilized by
both hydrophilic and hydrophobic interactions. The Basigin transmembrane glutamate
residue does play a role in the interaction between Basigin and TLR4 but is not entirely
responsible for stabilizing the interaction between Basigin and TLR4, as several other
amino acid residues appear to be key for the interaction in addition to the glutamate
residue. The TLR4 transmembrane domain contains two positively charged histidine
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residues that could be important for establishing electrostatic interactions with the Basigin
transmembrane glutamate residue.

Basigin transmembrane residues that appear to

stabilize the interaction between the Basigin and TLR4 are located within positions 1-18 in
the Basigin transmembrane domain.

Residues located in the 19-24 Basigin

transmembrane region do not appear to be as important as the other residues because the
observed binding affinity of residues 19-24 for TLR4 was significantly less than the binding
affinities of the other transmembrane regions of Basigin. This phenomenon allows Basigin
to interact with TLR4 and the transporter protein MCT1 simultaneously and hence
perform multiple tasks within the same cell.
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